Kayne Anderson Rudnick Investment Management’s Idexx Laboratories IDXX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $59.5M | Sell |
111,016
-8,171
| -7% | -$4.38M | 0.14% | 123 |
|
2025
Q1 | $50.1M | Sell |
119,187
-10,715
| -8% | -$4.5M | 0.12% | 135 |
|
2024
Q4 | $53.7M | Sell |
129,902
-6,695
| -5% | -$2.77M | 0.12% | 133 |
|
2024
Q3 | $69M | Sell |
136,597
-4,009
| -3% | -$2.03M | 0.15% | 122 |
|
2024
Q2 | $68.5M | Sell |
140,606
-6,194
| -4% | -$3.02M | 0.17% | 120 |
|
2024
Q1 | $79.3M | Sell |
146,800
-3,369
| -2% | -$1.82M | 0.18% | 118 |
|
2023
Q4 | $83.4M | Buy |
150,169
+683
| +0.5% | +$379K | 0.21% | 113 |
|
2023
Q3 | $65.4M | Sell |
149,486
-7,284
| -5% | -$3.19M | 0.19% | 121 |
|
2023
Q2 | $78.7M | Sell |
156,770
-2,209
| -1% | -$1.11M | 0.22% | 113 |
|
2023
Q1 | $79.5M | Sell |
158,979
-2,984
| -2% | -$1.49M | 0.23% | 114 |
|
2022
Q4 | $66.1M | Buy |
161,963
+52,784
| +48% | +$21.5M | 0.21% | 120 |
|
2022
Q3 | $35.6M | Buy |
109,179
+12,575
| +13% | +$4.1M | 0.12% | 139 |
|
2022
Q2 | $33.9M | Buy |
96,604
+2,370
| +3% | +$831K | 0.11% | 148 |
|
2022
Q1 | $51.6M | Sell |
94,234
-2,717
| -3% | -$1.49M | 0.14% | 140 |
|
2021
Q4 | $63.8M | Buy |
96,951
+422
| +0.4% | +$278K | 0.15% | 138 |
|
2021
Q3 | $60M | Buy |
96,529
+591
| +0.6% | +$368K | 0.15% | 138 |
|
2021
Q2 | $60.6M | Buy |
95,938
+204
| +0.2% | +$129K | 0.15% | 140 |
|
2021
Q1 | $46.8M | Buy |
95,734
+2,261
| +2% | +$1.11M | 0.13% | 145 |
|
2020
Q4 | $46.7M | Buy |
93,473
+7,034
| +8% | +$3.52M | 0.14% | 138 |
|
2020
Q3 | $34M | Buy |
86,439
+18,233
| +27% | +$7.17M | 0.12% | 145 |
|
2020
Q2 | $22.5M | Buy |
68,206
+22,921
| +51% | +$7.57M | 0.09% | 155 |
|
2020
Q1 | $11M | Buy |
45,285
+45,280
| +905,600% | +$11M | 0.06% | 165 |
|
2019
Q4 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 619 |
|